A brief review of chronic obstructive pulmonary disease

Canadian Respiratory Journal

Volumn 19, Issue 6, 2012, Pages 381-384

  Hogg, James C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Airway obstruction; Chronic airway inflammation; Emphysematous tissue destruction

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTASE; INOSINATE DEHYDROGENASE; LOSARTAN; METHIONINE; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; VASCULOTROPIN; WNT PROTEIN;

AIRWAY OBSTRUCTION; BOOK; BRONCHIOLE; CELL DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; EXPIRATION DATE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENETIC PREDISPOSITION; LUNG ALVEOLUS; LUNG INJURY; LUNG PARENCHYMA; MARFAN SYNDROME; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; SMOKING; STEM CELL; TISSUE REPAIR; TOXIC INHALATION; WILD TYPE;

EID: 84871031874     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/496563     Document Type: Review

References (31)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009) 〈www.goldcopd.org〉 (Accessed May 31, 2012).
2. Buist AS, McBurnie MA, Vollmer WM, et al; Bold study of the prevalence of obstructive lung disease International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet 2007;370:741-50. (Pubitemid 47321907)
3. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8l.
4. Weibel ER. Morphometry of the Human Lung. New York: Academic Press Inc; 1963.
5. Green M. How big are the bronchioles? St Thomas Hospital Gazette. 1965;63:136-9.
6. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;1355-60.
7. Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruction in pulmonary disease: Direct measurement of intrabronchial pressure. J Appl Physiol 1992;72:1016-23.
8. Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 1967;22:95-108.
9. Guenette JA, Webb KA, O'Donnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J 2012;40:322-9.
10. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365:1567-75.
11. Altschuler B, Yarmus L, Palmes ED, Nelson N. Aerosol deposition in the human respiratory tract. AMA Arch Ind Health 1957;15:292-303.
12. Leopold JG, Gough J. The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis. Thorax 1957;219-35.
13. Wynn TA, Ramalingam TR. Mechamisms of fibrosis: Therapeutic translation for fibrotic disease. Nat Med 2012;18:1028-40.
14. Kumar V, Abbas AK, Fausto N. Tissue renewal and repair. In: Robbins and Cotran pathologic basis of disease, 7th edn. Philadelphia: Elsevier Saunders; 2004:87-118.
15. Madden JW, Peacock EE Jr. Studies on the biology of collagen during wound healing. 3. Dynamic metabolism of scar collagen and remodeling of dermal wounds. Ann Surg 1971;174:511-20.
16. Laurell CB, Erikssin S. The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitripsin deficiency. Scand J Clin Invest 1963;15:132-40.
17. Kaplan PD, Kuhn C, Pierce JA. The induction of emphysema with elastase. I. The evolution of the lesion and the influence of serum. J Lab Clin Med 1973;82:349-56.
18. Carp H, Janoff A. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 1978;118:617-21. (Pubitemid 9027203)
19. Taggart C, Cervantes-Laurean D, Kim G, et al. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem 2000;275:27258-65.
20. Suzuki M, Betsuyaku T, Ito Y, et al. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2008;39:673-82.
21. Malhotra D, Thimmulappa R, Navas-Acien A, et al. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 2008;178:592-604.
22. Harvey CJ, Thimmulappa RK, Sethi S, et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med 2011;3:78ra32.
23. Togo S, Holz O, Liu X, et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008;178:248-60.
24. Zandvoort A, Postma DS, Jonker MR, Noordhoek JA, Vos JT, Timens W. Smad gene expression in pulmonary fibroblasts: Indications for defective ECM repair in COPD. Respir Res 2008;9:83.
25. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006;312:117-21.
26. Podowski M, Calvi C, Metzger S, et al. Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. J Clin Invest 2012;122:229-40.
27. Neptune ER, Frischmeyer PA, Arking DE, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003;33:407-411. (Pubitemid 36278859)
28. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-9.
29. Whyte JL, Smith AA, Helms JA. Wnt signaling and injury repair. Cold Spring Harb Perspect Biol 2012;4:a008078.
30. Kneidinger N, Yildirim AÖ, Callegari J, et al. Activation of the WNT/β-catenin pathway attenuates experimental emphysema. Am J Respir Crit Care Med 2011;183:723-33.
31. Seimetz M, Parajuli N, Pichl A, et al. Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell 2011;147:293-05.